GIANNOLA, Libero Italo
 Distribuzione geografica
Continente #
NA - Nord America 8.858
EU - Europa 5.018
AS - Asia 4.025
SA - Sud America 533
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 18.604
Nazione #
US - Stati Uniti d'America 8.729
SG - Singapore 1.529
RU - Federazione Russa 1.144
CN - Cina 1.048
IT - Italia 797
FI - Finlandia 705
UA - Ucraina 632
DE - Germania 436
HK - Hong Kong 419
BR - Brasile 406
VN - Vietnam 374
PL - Polonia 286
FR - Francia 248
IE - Irlanda 237
GB - Regno Unito 229
JP - Giappone 159
KR - Corea 103
SE - Svezia 95
IN - India 92
BD - Bangladesh 68
CI - Costa d'Avorio 68
CA - Canada 59
TR - Turchia 44
BE - Belgio 42
MX - Messico 39
AR - Argentina 38
NL - Olanda 38
RO - Romania 38
IQ - Iraq 32
CO - Colombia 28
ZA - Sudafrica 26
CH - Svizzera 18
EC - Ecuador 18
ES - Italia 18
SA - Arabia Saudita 18
PK - Pakistan 17
IR - Iran 16
ID - Indonesia 15
PH - Filippine 15
VE - Venezuela 15
EU - Europa 14
MA - Marocco 13
MY - Malesia 11
EG - Egitto 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
GR - Grecia 8
TW - Taiwan 7
UZ - Uzbekistan 7
DZ - Algeria 6
KE - Kenya 6
PT - Portogallo 6
BO - Bolivia 5
HU - Ungheria 5
JO - Giordania 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LT - Lituania 5
NP - Nepal 5
UY - Uruguay 5
AL - Albania 4
AT - Austria 4
BG - Bulgaria 4
CL - Cile 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HN - Honduras 4
JM - Giamaica 4
LB - Libano 4
AU - Australia 3
EE - Estonia 3
IL - Israele 3
NI - Nicaragua 3
NO - Norvegia 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
MU - Mauritius 2
OM - Oman 2
PE - Perù 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
Totale 18.591
Città #
Singapore 1.035
Ashburn 1.026
Fairfield 713
Chandler 594
San Jose 574
Woodbridge 479
Houston 467
Hong Kong 402
Ann Arbor 398
Wilmington 391
Jacksonville 362
Seattle 262
Dublin 237
Zgierz 237
Cambridge 229
Des Moines 202
Medford 197
Moscow 197
Beijing 180
Nanjing 174
Frankfurt am Main 151
Santa Clara 151
Tokyo 146
Boardman 138
Ho Chi Minh City 127
Dearborn 124
Princeton 119
Palermo 107
Los Angeles 104
Lauterbourg 101
Hanoi 96
New York 90
Tulsa 84
Council Bluffs 75
Altamura 74
Dallas 73
The Dalles 73
Abidjan 68
Hefei 58
Buffalo 52
Helsinki 50
Milan 50
Lawrence 46
São Paulo 46
Jinan 42
Venice 41
Shenyang 40
Nanchang 39
Brussels 38
Hebei 34
San Diego 34
Rome 32
Tianjin 31
Changsha 30
Chicago 30
Jiaxing 27
Ludwigshafen am Rhein 27
Amsterdam 25
Columbus 24
Orem 24
Warsaw 24
Düsseldorf 23
London 23
Seongnam 23
Kumar 22
Saint Petersburg 20
Atlanta 19
Denver 19
Montreal 18
Zhengzhou 17
Auburn Hills 16
Munich 16
Toronto 16
Ankara 15
City of London 15
Da Nang 15
Johannesburg 15
Verona 15
Norwalk 14
Poplar 14
Brooklyn 13
Guangzhou 13
Hangzhou 13
Phoenix 13
Rio de Janeiro 13
Washington 13
Chennai 12
Haiphong 12
Paris 12
San Francisco 12
Boston 11
Orange 11
Redwood City 11
Seoul 11
Turku 11
Kraków 10
San Mateo 10
Stockholm 10
Belo Horizonte 9
Dhaka 9
Totale 11.665
Nome #
Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation 311
Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three-Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile Delivery by Drug-Loaded Matrix Tablets 303
Inhibitory effects of N-valproyl-L-tryptophan on high potassium, low calcium and low magnesium-induced CA1 hippocampal epileptiform bursting activity in rat brain slices 290
Effects of gamma-irradiation on trehalose-hydroxyethylcellulose microspheres loaded with vancomycin 272
Acetaldehyde self-administration by a two-bottle choice paradigm: Consequences on emotional reactivity, spatial learning, and memory 270
Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system 270
N-valproyl-l-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug 248
Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features 240
Medium-term culture of normal human oral mucosa: a novel three-dimensional model to study the effectiveness of drugs administration. 238
A new delivery system of Clobetasol-17-propionate (lipid loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic-erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial, 237
Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design 235
Evaluation of Galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I 227
Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: A trial on pigs. 226
N-Valproyl-L-Phenylalanine as New Potential Antiepileptic Drug: Synthesis, Characterization and In Vitro Studies on Stability, Toxicity and Anticonvulsant Efficacy 224
3D OSCC model: effects following topical 5-FU delivery by drug-loaded tablets 223
Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation 220
Current status in buccal drug delivery 217
A new dopamine amino-acid conjugate: preclinical in vitro studies and evaluation of behavioural effects in rats 216
Comparative Study of the Effects Exerted by N-Valproyl-L-Phenylalanine and N-valproyl-L-tryptophan on CA1 Hippocampal Epileptiform Activity in Rat. 216
New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa 213
5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Reconstituted Human Oral Epithelium and Porcine Buccal Mucosa 210
Is Acetaldehyde a substance of abuse? Evidence from a free-access, three-bottle choice paradigm 209
Controlled delivery of naltrexone by an intraoral device:In vivo study on human subjects 206
Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence 206
Oral local drug delivery and new perspectives in oral drug formulation 205
Ambulatory Treatment and Telemonitoring of Patients with Parkinson’s Disease 204
Buccal delivery of Methimazole as an alternative means to optimize drug bioavailability: permeation studies and matrix system design 198
Optimization of local delivery of antifungal agents in the oral cavity by a new formulation 197
Buccal drug delivery: what’s new and what does the future hold? 195
Human Buccal Mucosa as an Innovative Site of Drug Delivery 194
Ocular gelling microspheres: in vitro Precorneal retention time and drug permeation through reconstituted corneal epithelium 194
Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent 194
In situ delivery of corticosteroids for treatment of oral diseases 194
A three-cell type in vitro-model of BBB 191
A new intraoral device to home assist Parkinson’s disease patients by distant control 190
Evaluation of the aptitude to cross the BBB of a new dopamine aminoacidic prodrug 189
New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies 188
Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue 188
Buccal delivery as a new challenge for treatment of motor fluctuations in Parkinson's Disease 182
Physical methods for enhancing oral mucosal delivery: Sonophoresis, iontophoresis and electroporation methods 181
Recent Advances in Drug Delivery from the Oral Cavity. Focus on innovative buccal drug delivery devices 180
5-Fluororacile-loaded matrix tablets for locoregional delivery: effects on a three-dimensional culture model of primary oral squamous cell carcinoma 180
A NEW DOPAMINE-AMINOACID CONJUGATE: SYNTHESIS AND DETERMINATION OF PHYSICO-CHEMICAL PROPERTIES USEFUL TO CROSS THE BBB 180
Aminoacidic derivatives as novel CNS-targeted neurotherapeutics 177
DESIGN AND CHARACTERIZATION OF MUCOADHESIVE SUBLINGUAL FILMS CONTAINING FUROSEMIDE 175
Buccal delivery in treatment of Alzheimer disease: enhancement of galantamine absorption 174
Small endogenous molecules as moiety to improve targeting of CNS drugs 174
DA-Phen as a new potential DA-mimetic agent for treatment of alcohol addiction: preclinical in vivo studies 173
CNS-targeted valproic-aminoacid conjugate: preliminary studies on pharmacokinetic parameters and antiepileptic activity 172
N-valproyl-aminoacids as new potential antiepileptic drugs: Synthesis, characterization and in vitro studies on stability 172
Drug delivery from the oral cavity: focus on a novel mechatronic delivery device 169
New horizons for OSCC chemotherapy: transmucosal permeability of 5-fluorouracil throughout porcine buccal mucosa 168
Aloin loaded matrix tablets for topical treatment of oral cancer 167
An intraoral drug delivery device for long term therapies: application in Alzheimer’s disease 166
Enteric Aloin loaded microparticles for treatment of colorectal cancer 165
Transbuccal delivery of l-dopa methyl ester: ex vivo permeation studies 163
DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator 163
Transbuccal tablets of carbamazepine: formulation, release and absorption pattern 159
MEDIUM-TERM CULTURE OF THE NORMAL ORAL MUCOSA: A NOVEL THREE-DIMENSIONAL MODEL TO STUDY THE EFFECTIVENESS OF DRUGS ADMINISTRATION 158
Galantamine delivery on buccal mucosa: permeation enhancement and design of matrix tablets 157
Lipid Phase Transition in Saccharide Coated Cholate containing liposomes: Coupling to the Surrounding Matrix 154
AMINOACID PRO-DRUG TO SHUTTLE VALPROIC ACID INTO CNS 152
Functional feature of a novel model of blood brain barrier: Studies on permeation of test compounds 149
DOPAMINE PRO-DRUGS FOR CNS TARGETING: SYNTHESIS, CHARACTERIZATION AND HYDROLYSIS BY BRAIN ENZYMES. 147
PARTICELLE MICROMETRICHE, LORO METODO DI PREPARAZIONE E LORO USI 147
Ambulante Therapie & Telemonitoring von Patienten mit Parkinson 145
Physical methods to promote drug delivery on mucosal tissues of the oral cavity 145
Ex vivo transbuccal delivery of carbamazepine across porcine mucosa 143
Buccal Delivery of Carbamazepine (CBZ): a New Scenario in Menagement of Trigeminal Neuralgia (TN) 143
N-valplroyl-aminoacids as new potential antiepileptic drugs: synthesis, characterization and in vitro studies on stability 139
Formulation and kinetic studies on matrix tablets loaded with 5-Fluorouracil useful in oral cancer treatment 138
Electronic buccal drug delivery system to treat addiction and chronic diseases,porcine study in the frame of "Intellidrug"project 136
Neurons and ECM regulate occludin localization in brain endothelial cells 135
Naltrexone-loaded matrices: preparation, drug release and absorption through reconstituted buccal human epithelium 134
Trehalose-loaded liposomes to regulate skin moisturization 134
Lipid Phase Transition in Saccharide-Coated Cholate-Containing Liposomes: Coupling to the Surrounding Matrix 130
Potential dopamine prodrug-loaded liposomes: preparation, characterization, and in vitro stability studies 130
Synthesis and in vitro studies on a potential dopamine prodrug 127
Sintesi, caratterizzazione e studio della stabilità chimica ed enzimatica di nuovi profarmaci della dopamina 126
Formulazione di sistemi innovativi per la somministrazione di antitumorali per il trattamento del Carcinoma Orale Squamoso 124
Matrix system development, permeation studies and histological features for transbuccal delivery of Naltrexone 123
Electronic buccal drug delivery system to treat addiction and chronic diseases: a porcine study in the frame of "IntelliDrug" project 123
Inclusion of Trehalose (TRH) into liposomes to regulate uptake of this cryoprotectant into human hepatocytes. 123
Progettazione e realizzazione di sistemi di rilascio programmato nella terapia delle ferite da ustione 122
Transmucosal delivery della Galantamina attraverso mucosa buccale ex vivo 120
Buccal delivery for systemic and local therapies: new in vitro studies 119
Trehalose stabilizing effects on L-DOPA aqueous solutions 119
Tablets for buccal administration of carbamazepine: comparative behavior of PAA microspheres and matrices 116
Clinical Trial and Bioavailability of Naltrexone 112
Efficacy of 5-FU topically applied on a buccal mucosal model resembling human tissue. A new chance for OSCC chemotherapy. 112
Modulation of alcohol consumption using an operant self-administration paradigm: effects of a new dopamine aminoacidic conjugate, Phenylalanine-β(3,4dihydroxyphenyl)-etilamide. 110
Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa 108
Drug movements in biologic environment and through the membranes 107
New applications of Buccal delivery 106
Transbuccal delivery of methimazole: ex vivo permeation studies, histomorphological features and matrix system development 106
“In vitro studies, emphasis on the preparation of the drugs in matrices”. 104
How a buccal device should deliver drugs: aspects of drug formulation related to taste and penetration enhancers 104
Iontoforesis and drug absorption through reconstituted buccal human epithelium 103
Transmucosal permeability model of 5-fluorouracil through porcine and reconstituted oral epithelium 103
Loaded sulfamethoxazole/trimethoprim soft films for treatment of burn wounds. 103
Totale 17.224
Categoria #
all - tutte 60.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.170 40 286 25 32 42 41 45 69 140 130 55 265
2022/20231.687 188 237 28 179 208 275 145 131 202 17 59 18
2023/2024714 28 114 45 58 49 149 52 56 3 13 20 127
2024/20251.800 60 75 157 191 84 29 138 103 81 209 241 432
2025/20266.770 461 147 302 507 621 939 1.008 778 513 1.049 237 208
2026/202767 67 0 0 0 0 0 0 0 0 0 0 0
Totale 19.021